MedPath

Myofascial Pain Syndrome and Dextrose Prolotherapy

Phase 4
Conditions
Efficacy of Dextrose Prolotherapy in Myofascial Pain Syndrome
Interventions
Drug: Local anesthetic and saline injection to the myofascial trigger point
Drug: Injection of dextrose, local anesthetic and saline to the myofascial trigger point
Registration Number
NCT04941118
Lead Sponsor
Mustafa Kemal University
Brief Summary

Myofascial pain syndrome is characterized by the presence of hypersensitive points called trigger points that cause pain, tenderness, spasm, stiffness, limitation of movement, weakness, taut band within the muscle, and pain reflected by pressing in a muscle group or a single muscle.

Prolotherapy is a regenerative treatment method in the treatment of chronic musculoskeletal pain, in which an irritating solution is injected, often hypertonic dextrose, into painful ligament and tendon attachments and adjacent joint spaces.

In this study, it was aimed to examine the effect of prolotherapy application on pain, neck range of motion and neck disability in women with myofascial pain syndrome.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
Female
Target Recruitment
60
Inclusion Criteria
  • 60 women aged 20-50 years with a diagnosis of myofascial pain syndrome
Exclusion Criteria
  • Cervical radiculopathy, cervical degeneration, neck surgery or trauma in the last year, injection history for myofascial pain syndrome in the last 6 months, cognitive impairment and fibromyalgia, rheumatoid arthritis, hypothyroidism, diabetes mellitus

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Control groupLocal anesthetic and saline injection to the myofascial trigger pointOnly saline and local anesthetic (lidocaine)
Dextrose prolotherapy groupInjection of dextrose, local anesthetic and saline to the myofascial trigger pointDextrose, saline and local anesthetic (lidocaine)
Primary Outcome Measures
NameTimeMethod
Visual Analog ScaleFirst month post-treatment

0-10 cm visual scale (0: no pain, 10: most severe pain)

Neck Disability IndexFirst month post-treatment

It measures the functional state of the neck by scoring between 0-5 points according to the severity of pain, consisting of 20 questions.

Neck joint range of motion measurementFirst month post-treatment

Active neck range of motion, which shows the movement of the neck in all directions, is evaluated by goniometric measurement.

Secondary Outcome Measures
NameTimeMethod
Side effectsThrough study completion, an average of 6 month.

Edema, ecchymosis, hematoma, allergic reaction, exacerbation of pain, systemic or distant side effects

Trial Locations

Locations (1)

Hatay Mustafa Kemal University, Tayfur Ata Sökmen Faculty of Medicine

🇹🇷

Hatay, Turkey

© Copyright 2025. All Rights Reserved by MedPath